Patent Issued for Compositions of b-aminoisobutyric acid and methods for use thereof (USPTO 11766416).

"Recently, b-aminoisobutyric acid (BAIBA) has generated interest in the scientific literature as a potential treatment for obesity and related conditions, such as pre-obesity and hyperglycemia. Adipokines, Amino Acids, Aminoisobutyric Acid, Bariatrics, Branched-Chain Amino Acids, Business, Diet and Nutrition, Drugs and Therapies, Endocrine System Diseases and Conditions, Glucose Metabolism Disorders, Health and Medicine, Hyperinsulinism, Insulin Resistance, Intercellular Signaling Peptides and Proteins, Leptin, Lipid Research, Lipids, Lipoproteins, Metabolism, Nanjing Nutrabuilding Bio-Tech Co. Ltd., Nutrition Disorders, Nutritional and Metabolic Diseases and Conditions, Obesity, Obesity and Diabetes, Overnutrition, Peptide Hormones, Peptide Proteins, Peptides and Proteins, Proinsulin, Risk and Prevention, Wellness. [Extracted from the article]